Robert C. Green, MD, MPH is a medical geneticist and physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School. Dr. Green is internationally recognized for designing and conducting empirical studies in genomic medicine. He led the first experimental trials disclosing common complex disease risk (the REVEAL Study) and one of the first prospective studies of direct-to-consumer genetic testing services (the PGen Study). He was lead author on the influential recommendations for managing incidental findings in clinical sequencing from the American College of Medical Genetics and Genomics and a co-author on recommendations for managing incidental findings in research biobanks. He co-chairs the Steering Committee of the NIH Consortium on Clinical Sequencing Exploratory Research (CSER) and is a member of funded teams in the CSER Consortium, the NSIGHT (Newborn Sequencing in Genomic Medicine and Public Health) Consortium and the eMERGE (Electronic Medical Records and Genomics) Consortium. He currently leads and co-leads the MedSeq Project and the BabySeq Project, respectively, two NIH-funded randomized trials designed to explore the medical, behavioral and economic implications of integrating genome sequencing into the medical care of adults and newborns. Most recently, Dr. Green’s team was recently awarded funding from the Department of Defense for the first pilot study of genomic medicine in the active duty military.

Additional information: Dr. Green graduated from Amherst College and the University of Virginia School of Medicine, and earned a Masters of Public Health in epidemiology from Emory University School of Public Health. He obtained clinical specialty training at Harvard Medical School and is board certified in both neurology and medical genetics. He has been continuously funded by NIH for over 26 years and has published over 300 papers with an h index of 60. He was awarded the 2014 Coriell Award for Scientific Achievement in Personalized Medicine. He is currently Associate Director for Research of Partners HealthCare Personalized Medicine and a Board Member of the Council for Responsible Genetics.

Key scientific contributions include publication of the first randomized trials to assess the impact of common complex genetic risk markers, empirical studies describing the medical and behavioral outcomes of direct-to-consumer genetic testing, and design of a single page summary for reporting whole genome sequencing to physicians. Dr. Green teaches medical students and mentors post-doctoral trainees and junior faculty in the clinical and research aspects of genomic medicine. Keynote and plenary presentations include the American College of Medical Genetics and Genomics, Cold Spring Harbor, World Congress of Psychiatric Genetics, Human Genome Variation Society, European Society for Human Genetics, the Forbes Healthcare Summit, the World Science Festival and Festival of Genomics. His work has been featured on PBS radio and television documentaries, and repeatedly highlighted in NBC Nightly News, the Today Show, the New York Times, the Wall Street Journal, Time Magazine, New Scientist, FastCompany, GenomeWeb and Buzzfeed.

Healthcare